Journal of the Neurological Sciences
Volume 283, Issue 1 , Pages 139-142 , 15 August 2009

Depression and dementia

  • Amos D. Korczyn

      Affiliations

    • Tel-Aviv University Medical School, Sieratzki Chair of Neurology, Ramat-Aviv 69978, Israel
    • Corresponding Author InformationCorresponding author. Tel.: +972 3 6974229; fax: +972 3 6409113.
    • ,
  • Ilan Halperin

      Affiliations

    • Tel-Aviv Sourasky Medical Center, Department of Neurology, Memory clinic, Tel-Aviv 64239, Israel
    • Tel.: +972 50 6877714; fax: +972 57 7948657.

References 

  1. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54:S10–S15
  2. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54:S4–S9
  3. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 2000;54:2072–2077
  4. Carlson MC, Helms MJ, Steffens DC, Burke JR, Potter GG, Plassman BL. Midlife activity predicts risk of dementia in older male twin pairs. Alzheimers Dement. 2008;4:324–331
  5. Fernandez Martinez M, Castro Flores J, Perez de Las Heras S, Mandaluniz Lekumberri A, Gordejuela Menocal M, Zarranz Imirizaldu JJ. Risk factors for dementia in the epidemiological study of Munguialde County (Basque Country-Spain). BMC Neurol. 2008;8:39
  6. Korczyn AD. Mixed dementia — the most common cause of dementia. Ann N Y Acad Sci. 2002;977:129–134
  7. Emery VO, Oxman TE. Update on the dementia spectrum of depression. Am J Psychiatry. 1992;149:305–317
  8. Halperin I, Korczyn AD. Depression precedes future development of dementia. Future Neurol. 2007;2:201–208
  9. Kral VA. Depressive pseudodementia and Alzheimer's disease — a pilot study. Nervenarzt. 1982;53:284–286
  10. Neu P, Bajbouj M, Schilling A, Godemann F, Berman RM, Schlattmann P. Cognitive function over the treatment course of depression in middle-aged patients: correlation with brain MRI signal hyperintensities. J Psychiatr Res. 2005;39:129–135
  11. Hammar A, Lund A, Hugdahl K. Long-lasting cognitive impairment in unipolar major depression: a 6-month follow-up study. Psychiatry Res. 2003;118:189–196
  12. Ballard C, Day S, Sharp S, Wing G, Sorensen S. Neuropsychiatric symptoms in dementia: importance and treatment considerations. Int Rev Psychiatry. 2008;20:396–404
  13. Sáez-Fonseca JA, Lee L, Walker Z. Long-term outcome of depressive pseudodementia in the elderly. J Affect Disord. 2007;101:123–129
  14. Wilson RS, Schneider JA, Bienias JL, Arnold SE, Evans DA, Bennett DA. Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology. 2003;61:1102–1107
  15. Kessing LV, Nilsson FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord. 2003;73:261–269
  16. Nilsson FM, Kessing LV, Sørensen TM, Andersen PK, Bolwig TG. Enduring increased risk of developing depression and mania in patients with dementia. J Neurol Neurosurg Psychiatry. 2002;73:40–44
  17. Wilson RS, Barnes LL, Mendes de Leon CF, Aggarwal NT, Schneider JS, Bach J, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 2002;59:364–370
  18. Yaffe K, Blackwell T, Gore R, Sands L, Reus V, Browner W. Depressive symptoms and cognitive decline in nondemented elderly women. Arch Gen Psychiatry. 1999;56:425–430
  19. Butters MA, Young JB, Lopez O, Aizenstein HJ, Mulsant BH, Reynolds CF, et al. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci. 2008;10:345–357
  20. Chen R, Hu Z, Wei L, Qin X, McCracken C, Copeland JR. Severity of depression and risk for subsequent dementia: cohort studies in China and the UK. 1: Br J Psychiatry. 2008;193:373–377
  21. Migliorelli R, Tesón A, Sabe L, Petracchi M, Leiguarda R, Starkstein SE. Prevalence and correlates of dysthymia and major depression among patient with Alzheimer's disease. Am J Psychiatry. 1995;152:37–44
  22. Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D, et al. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry. 1996;53:175–182
  23. Alexopoulos GS. Depression in the elderly. Lancet. 2005;365:1961–1970
  24. American Psychiatric Association . Diagnostic and statistical manual of mental disorders DSM-IV. Washington DC: APA; 1994;
  25. Murphy BM, Elliott PC, Higgins RO, Le Grande MR, Worcester MU, Goble AJ, et al. Anxiety and depression after coronary artery bypass graft surgery: most get better, some get worse. Eur J Cardiovasc Prev Rehabil. 2008;15:434–440
  26. Blumenthal JA. Depression and coronary heart disease: association and implications for treatment. Cleve Clin J Med. 2008;75:S48–S53
  27. Sparks DL. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease?. Ann N Y Acad Sci. 1997;826:128–146
  28. Chen Z, Skolnick P. Triple uptake inhibitors: therapeutic potential in depression and beyond. Expert Opin Investig Drugs. 2007;6:1365–1377
  29. Reinikainen KJ, Soininen H, Riekkinen PJ. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy. J Neurosci Res. 1990;27:576–586
  30. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry. 2000;57:1071–1076
  31. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. Vascular depression' hypothesis. Arch Gen Psychiatry. 1997;54:915–922
  32. Alexopoulos GS, Murphy CF, Gunning-Dixon FM, Latoussakis V, Kanellopoulos D, Klimstra S, et al. Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry. 2008;165:238–244
  33. Hirono N, Kitagaki H, Kazui H, Hashimoto M, Mori E. Impact of white matter changes on clinical manifestation of Alzheimer's disease: a quantitative study. Stroke. 2000;31:2182–2188
  34. Parnetti L. Pathophysiology of vascular dementia and white matter changes. Rev Neurol (Paris). 1999;155:754–758
  35. van de Pol LA, Hensel A, Barkhof F, Gertz HJ, Scheltens P, van der Flier WM. Hippocampal atrophy in Alzheimer disease: age matters. Neurology. 2006;66:236–238
  36. Barber R, Ballard C, McKeith IG, Gholkar A, O'Brien JT. MRI volumetric study of dementia with Lewy bodies. A comparison with AD and vascular dementia. Neurology. 2000;54:1304–1309
  37. Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry. 2003;160:1516–1518
  38. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatry. 2000;157:115–118
  39. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev. 1986;7:284–301
  40. Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev. 2005;4:141–194
  41. López JF, Chalmers DT, Little KY, Watson SJ. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry. 1998;43:547–573
  42. De Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M. Brain corticosteroid receptor balance in health and disease. Endocr Rev. 1998;19:269–301
  43. Sapolsky RM. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry. 2000;48:713–714
  44. Lee AL, Ogle WO, Sapolsky RM. Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord. 2002;4:117–128
  45. Carney RM, Freedland KE, Veith RC, Jaffe AS. Can treating depression reduce mortality after an acute myocardial infarction?. Psychosom Med. 1999;61:666–675
  46. Lenzi GL, Altieri M, Maestrini I. Post-stroke depression. Rev Neurol (Paris). 2008;164:837–840
  47. Rennert NJ, Charney P. Preventing cardiovascular disease in diabetes and glucose intolerance: evidence and implications for care. Prim Care. 2003;30:569–592
  48. Duron E, Hanon O. Hypertension, cognitive decline and dementia. Arch Cardiovasc Dis. 2008;101:181–189

PII: S0022-510X(09)00426-2

doi: 10.1016/j.jns.2009.02.346

Journal of the Neurological Sciences
Volume 283, Issue 1 , Pages 139-142 , 15 August 2009

Article Tools